Oxidative Stress Assay Market Size

Oxidative Stress Assay Market Size

The global oxidative stress assay market size was valued at USD 1.1 billion in 2023 and is estimated to grow at 9.8% CAGR from 2024 to 2032. Oxidative stress assays are laboratory tests that measure oxidative stress biomarkers in biological samples such as blood, urine, or tissue. By evaluating the balance between reactive oxygen species (ROS) and antioxidants, these assays provide insights into the extent of oxidative damage to cells and tissues.

To get key market trends

  Download Free Sample

The rising prevalence of chronic diseases, including cardiovascular diseases, diabetes, cancer, and chronic respiratory diseases, is significantly driving the market's growth. For example, cardiovascular diseases top the list of non-communicable disease (NCD)-related deaths, claiming 17.9 million lives annually, followed by cancers (9.3 million deaths), chronic respiratory diseases (4.1 million deaths), and diabetes (2.0 million deaths, including those from diabetes-related kidney disease). Together, these four categories account for over 80% of all premature NCD deaths, highlighting the increasing demand for oxidative stress assays, given the pivotal role of oxidative stress in the onset and progression of these chronic conditions.
 

Moreover, technological advancements in diagnostics, heightened awareness of antioxidant therapies, and intensified research in drug discovery and development are further propelling demand for oxidative stress assays.